Adhesins in Candida glabrata
- PMID: 29783771
- PMCID: PMC6023314
- DOI: 10.3390/jof4020060
Adhesins in Candida glabrata
Abstract
The human fungal pathogen Candida glabrata is causing more and more problems in hospitals, as this species shows an intrinsic antifungal drug resistance or rapidly becomes resistant when challenged with antifungals. C. glabrata only grows in the yeast form, so it is lacking a yeast-to-hyphae switch, which is one of the main virulence factors of C. albicans. An important virulence factor of C. glabrata is its capacity to strongly adhere to many different substrates. To achieve this, C. glabrata expresses a large number of adhesin-encoding genes and genome comparisons with closely related species, including the non-pathogenic S. cerevisiae, which revealed a correlation between the number of adhesin-encoding genes and pathogenicity. The adhesins are involved in the first steps during an infection; they are the first point of contact with the host. For several of these adhesins, their importance in adherence to different substrates and subsequent biofilm formation was demonstrated in vitro or in vivo. In this review, we provide an overview of the role of C. glabrata adhesins during adhesion and biofilm formation both, under in vitro and in vivo conditions.
Keywords: Candida glabrata; adhesin; adhesion; biofilm.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- European Centre for Disease Prevention and Control . Annual Epidemiological Report 2016—Surgical Site Infections. European Centre for Disease Prevention and Control; Solna City, Sweden: 2016.
-
- European Centre for Disease Prevention and Control Healthcare-Associated Infections Acquired in Intensive Care Units. [(accessed on 2 April 2018)]; Available online: https://ecdc.europa.eu/en/publications-data/healthcare-associated-infect....
-
- Zarb P., Coignard B., Griskeviciene J., Muller A., Vankerckhoven V., Weist K., Goossens M., Vaerenberg S., Hopkins S., Catry B., et al. The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Eurosurveillance. 2012;17:20316. doi: 10.2807/ese.17.46.20316-en. - DOI - PubMed
-
- Pfaller M.A., Diekema D.J., Gibbs D.L., Newell V.A., Ellis D., Tullio V., Rodloff A., Fu W., Ling T.A. Global Antifungal Surveillance Group. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: A 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J. Clin. Microbiol. 2010;48:1366–1377. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
